Rating History for Millendo Therapeutics Inc. (MLND) by Ladenburg Thalmann
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/6/2021 | Matthew Kaplan | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.69 (1.06) |
-37.28% | Details |
 |
|||||||
|
|||||||
|
|||||||
